Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
52.3M
-
Shares change
-
+19.7M
-
Total reported value, excl. options
-
$272M
-
Value change
-
+$102M
-
Put/Call ratio
-
0.51
-
Number of buys
-
36
-
Number of sells
-
-26
-
Price
-
$5.19
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q4 2021
83 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q4 2021.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.3M shares
.
Largest 10 shareholders include Blackstone Inc (18M shares), Syncona Portfolio Ltd (7.35M shares), Nantahala Capital Management, LLC (4.08M shares), FRAZIER MANAGEMENT LLC (3.75M shares), Capital World Investors (2.96M shares), Polygon Management Ltd. (2.7M shares), CITADEL ADVISORS LLC (1.7M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.67M shares), FMR LLC (1.64M shares), and Pendal Group Ltd (1.44M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.